308 related articles for article (PubMed ID: 16534538)
41. Systematic review of studies of productivity loss due to rheumatoid arthritis.
Burton W; Morrison A; Maclean R; Ruderman E
Occup Med (Lond); 2006 Jan; 56(1):18-27. PubMed ID: 16286432
[TBL] [Abstract][Full Text] [Related]
42. How much of the productivity losses among psoriasis patients are due to psoriasis.
Mustonen A; Mattila K; Leino M; Koulu L; Tuominen R
BMC Health Serv Res; 2015 Mar; 15():87. PubMed ID: 25888995
[TBL] [Abstract][Full Text] [Related]
43. Costs of Health Service Use among Unemployed and Underemployed People with Mental Health Problems.
Waldmann T; Staiger T; Ruesch N; Kilian R
J Ment Health Policy Econ; 2021 Mar; 24(1):31-41. PubMed ID: 33739934
[TBL] [Abstract][Full Text] [Related]
44. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
[TBL] [Abstract][Full Text] [Related]
45. Productivity loss of Japanese patients with rheumatoid arthritis - A cross-sectional survey.
Sruamsiri R; Mahlich J; Tanaka E; Yamanaka H
Mod Rheumatol; 2018 May; 28(3):482-489. PubMed ID: 28849715
[TBL] [Abstract][Full Text] [Related]
46. Economic evaluation of an intervention program with the aim to improve at-work productivity for workers with rheumatoid arthritis.
Noben C; Vilsteren MV; Boot C; Steenbeek R; Schaardenburg DV; Anema JR; Evers S; Nijhuis F; Rijk A
J Occup Health; 2017 May; 59(3):267-279. PubMed ID: 28381814
[TBL] [Abstract][Full Text] [Related]
47. Sick leave days and costs associated with overweight and obesity in Germany.
Lehnert T; Stuhldreher N; Streltchenia P; Riedel-Heller SG; König HH
J Occup Environ Med; 2014 Jan; 56(1):20-7. PubMed ID: 24351899
[TBL] [Abstract][Full Text] [Related]
48. Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.
Kleinman NL; Cifaldi MA; Smeeding JE; Shaw JW; Brook RA
J Occup Environ Med; 2013 Mar; 55(3):240-4. PubMed ID: 23471034
[TBL] [Abstract][Full Text] [Related]
49. Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland.
Holko P; Kawalec P; Mossakowska M; Pilc A
PLoS One; 2016; 11(12):e0168586. PubMed ID: 27992531
[TBL] [Abstract][Full Text] [Related]
50. Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.
Boonen A; van der Heijde D; Landewé R; Spoorenberg A; Schouten H; Rutten-van Mölken M; Guillemin F; Dougados M; Mielants H; de Vlam K; van der Tempel H; van der Linden S
Ann Rheum Dis; 2002 May; 61(5):429-37. PubMed ID: 11959767
[TBL] [Abstract][Full Text] [Related]
51. The indirect costs of cancer-related absenteeism in the workplace in Poland.
Macioch T; Hermanowski T
J Occup Environ Med; 2011 Dec; 53(12):1472-7. PubMed ID: 22045222
[TBL] [Abstract][Full Text] [Related]
52. [Medical and economic aspects of rheumatoid arthritis].
Fautrel B; Gaujoux-Viala C
Bull Acad Natl Med; 2012 Oct; 196(7):1295-305; discussion 1305-6. PubMed ID: 23815015
[TBL] [Abstract][Full Text] [Related]
53. The indirect costs of systemic autoimmune diseases, systemic lupus erythematosus, systemic sclerosis and sarcoidosis: a summary of 2012 real-life data from the Social Insurance Institution in Poland.
Kawalec PP; Malinowski KP
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(4):667-73. PubMed ID: 26153642
[TBL] [Abstract][Full Text] [Related]
54. Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.
Newhall-Perry K; Law NJ; Ramos B; Sterz M; Wong WK; Bulpitt KJ; Park G; Lee M; Clements P; Paulus HE
J Rheumatol; 2000 May; 27(5):1156-63. PubMed ID: 10813281
[TBL] [Abstract][Full Text] [Related]
55. Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
Behrens F; Tony HP; Koehm M; Schwaneck EC; Gnann H; Greger G; Burkhardt H; Schmalzing M
Clin Rheumatol; 2020 Sep; 39(9):2583-2592. PubMed ID: 32206973
[TBL] [Abstract][Full Text] [Related]
56. Evolution of cost structures in rheumatoid arthritis over the past decade.
Huscher D; Mittendorf T; von Hinüber U; Kötter I; Hoese G; Pfäfflin A; Bischoff S; Zink A;
Ann Rheum Dis; 2015 Apr; 74(4):738-45. PubMed ID: 24406543
[TBL] [Abstract][Full Text] [Related]
57. Early versus late initiation of rehabilitation after lumbar spinal fusion: economic evaluation alongside a randomized controlled trial.
Oestergaard LG; Christensen FB; Nielsen CV; Bünger CE; Fruensgaard S; Sogaard R
Spine (Phila Pa 1976); 2013 Nov; 38(23):1979-85. PubMed ID: 23928716
[TBL] [Abstract][Full Text] [Related]
58. Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-up.
Husberg M; Bernfort L; Hallert E
Scand J Rheumatol; 2018 Sep; 47(5):378-383. PubMed ID: 29611446
[TBL] [Abstract][Full Text] [Related]
59. [Convalescence, sick leave and health economics].
Nyhus M; Søgaard J
Ugeskr Laeger; 2009 Sep; 171(40):2888-92. PubMed ID: 19814933
[TBL] [Abstract][Full Text] [Related]
60. [Financial expenses incurred by herniated disk in health professionals].
Zonana-Nacach A; Moreno-Cazares MC; Gómez-Naranjo R
Cir Cir; 2013; 81(5):400-4. PubMed ID: 25125057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
